BSX Stock Recent News

BSX LATEST HEADLINES

BSX Stock News Image - Zacks Investment Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research 2024 Mar 01
BSX Stock News Image - Reuters

Boston Scientific said on Friday the U.S. Food and Drug Administration has approved its device to treat a complication of heart disease.

Reuters 2024 Mar 01
BSX Stock News Image - Zacks Investment Research

Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Investment Research 2024 Feb 27
BSX Stock News Image - Forbes

Boston Scientific BSX (NYSE: BSX) reported its Q4 results last month, with revenues and earnings comfortably beating the street estimates. The company reported revenue of $3.7 billion and adjusted earnings of $0.55 per share, compared to the consensus estimates of $3.6 billion and $0.51, respectively.

Forbes 2024 Feb 23
BSX Stock News Image - Zacks Investment Research

Boston Scientific (BSX) is benefitting from an impressive gain in MedSurg market share and the strong adoption of WATCHMAN FLX.

Zacks Investment Research 2024 Feb 21
BSX Stock News Image - Zacks Investment Research

Boston Scientific (BSX) announces the completion of its first commercial cases with its FDA-cleared Farapulse PFA System in the United States.

Zacks Investment Research 2024 Feb 20
BSX Stock News Image - Zacks Investment Research

Investors are optimistic about Boston Scientific (BSX) on strength across the target market and upbeat guidance.

Zacks Investment Research 2024 Feb 08
BSX Stock News Image - Zacks Investment Research

Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research 2024 Feb 02
BSX Stock News Image - Zacks Investment Research

Boston Scientific (BSX) secures FDA approval for the FARAPULSE PFA system.

Zacks Investment Research 2024 Feb 02
BSX Stock News Image - Zacks Investment Research

Boston Scientific (BSX) sees an increase in organic and operational revenues in its core business segments and geographies in the reported quarter.

Zacks Investment Research 2024 Jan 31
10 of 50